OneMedNet Corp financial data

Symbol
ONMD, ONMDW on Nasdaq
Industry
Services-Commercial Physical & Biological Research
Location
Trident Court, 1 Oakcroft Road, Chessington, Surrey, United Kingdom
State of incorporation
DE
Fiscal year end
December 31
Former names
Data Knights Acquisition Corp. (to 11/7/2023)
Latest financial report
10-K - Q4 2024 - Apr 15, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 13.1 % +657%
Debt-to-equity -115 % -80.2%
Return On Equity 62.2 % -39.1%
Return On Assets -409 % -90.9%
Operating Margin -1.49K % -123%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 30.8M shares +29%
Common Stock, Shares, Outstanding 28M shares +18.7%
Entity Public Float 9.7M USD
Common Stock, Value, Issued 2K USD 0%
Weighted Average Number of Shares Outstanding, Basic 28.1M shares +286%
Weighted Average Number of Shares Outstanding, Diluted 28.1M shares +286%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 643K USD -37%
Cost of Revenue 924K USD -19.7%
Research and Development Expense 1.47M USD -29%
Selling and Marketing Expense 830K USD -25.6%
General and Administrative Expense 7.03M USD +98.3%
Operating Income (Loss) -9.61M USD -40.2%
Nonoperating Income (Expense) -522K USD +98.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -33.8M USD -10.9%
Income Tax Expense (Benefit) 18K USD
Net Income (Loss) Attributable to Parent -10.1M USD +70%
Earnings Per Share, Basic -0.36 USD/shares +92.3%
Earnings Per Share, Diluted -0.36 USD/shares +92.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 172K USD +266%
Accounts Receivable, after Allowance for Credit Loss, Current 213K USD +40.1%
Assets, Current 3.62M USD +892%
Property, Plant and Equipment, Net 108K USD +9.09%
Assets 3.73M USD +703%
Accrued Liabilities, Current 2.84M USD
Liabilities, Current 19.2M USD +39%
Other Liabilities, Noncurrent 449K USD +560%
Liabilities 19.7M USD +41.5%
Retained Earnings (Accumulated Deficit) -102M USD -11.1%
Stockholders' Equity Attributable to Parent -16M USD -18.7%
Liabilities and Equity 3.73M USD +703%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.55M USD -54.4%
Net Cash Provided by (Used in) Financing Activities 1.68M USD +91.8%
Net Cash Provided by (Used in) Investing Activities -6K USD +98.4%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 28.2M shares +19.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 127K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.54K USD -99.3%
Deferred Tax Assets, Valuation Allowance 9.55M USD +23.2%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 9.73M USD +25.5%
Payments to Acquire Property, Plant, and Equipment 6K USD
Property, Plant and Equipment, Gross 324K USD +5.54%
Deferred Tax Assets, Operating Loss Carryforwards 9.09M USD +23%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 86.1M USD +10.4%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 11K USD +83.3%
Deferred Tax Assets, Net of Valuation Allowance 183K USD +2950%
Share-based Payment Arrangement, Expense 628K USD -57.4%
Interest Expense 14K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%